MDxHealth SA

MDXH Healthcare Diagnostics & Research

MDxHealth SA’s revenue for fiscal 2025 (year ended December 2025) was $107.9 million, up 19.8% from fiscal 2024. In the quarter to June 2026, revenue grew 12.0%, EPS fell 15.8%, free cash flow fell 200.2% and total debt rose 26.0%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

0.21 0.39 −65.00%
Market cap
$57.6M
P/E
0.0×
Fwd P/E
−0.8×
Dividend yield
—
F-score
4/9
Altman Z
−2.71
Beneish M
−3.54
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Piotroski F-Score
— 4 4 4

+8 more TTM periods

ROE
238.67% 491.05% (2,401.75%) (807.44%)
ROA
(27.38%) (20.86%) (21.61%) (22.62%)
ROIC
(23.77%) (30.97%) (25.09%) (24.54%)
Return on Tangible Assets
(404.34%) (113.57%) (377.87%) (282.31%)
Average Days of Receivables
47.46 46.53 49.04 66.71
Free Cash Flow per Share
(0.11) (0.04) (0.07) (0.14)
Free Cash Flow
(6.02) (2.09) (3.35) (6.98)
Other line items

Show all line items

Columns are period end dates